What is the treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo

For impetigo, the first-line treatment is topical mupirocin 2% ointment applied three times daily for 5-7 days for limited lesions, while oral antibiotics such as dicloxacillin or cephalexin are recommended for extensive disease. 1

First-Line Treatment: Topical Antibiotics

  • Mupirocin 2% ointment is FDA-approved for topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes, applied three times daily for 5-7 days 2, 1
  • Retapamulin 1% ointment is an effective alternative, applied twice daily for 5 days in patients aged 9 months or older 3, 1
  • Topical antibiotics have shown better cure rates than placebo (risk ratio 2.24) in clinical studies 4
  • Topical therapy is preferred for limited lesions due to fewer systemic side effects compared to oral antibiotics 5

Second-Line Treatment: Oral Antibiotics

Oral antibiotics should be used in the following scenarios:

  • Extensive disease with multiple lesions 1, 6
  • When topical therapy is impractical 1
  • Failure of topical treatment 1
  • Presence of systemic symptoms 6

Recommended oral antibiotics:

  • For Methicillin-Susceptible S. aureus (MSSA):

    • Dicloxacillin 250 mg four times daily for adults 6
    • Cephalexin 250-500 mg four times daily for adults 6, 1
    • First-generation cephalosporins 1
  • For Methicillin-Resistant S. aureus (MRSA):

    • Trimethoprim-sulfamethoxazole 1, 5
    • Clindamycin 300-450 mg three times daily for adults 6, 1
    • Doxycycline (not for children under 8 years) 6, 5

Special Considerations

Community-Acquired MRSA (CA-MRSA)

  • Consider empiric therapy for CA-MRSA in the following situations:
    • Patients at risk for CA-MRSA infection 1
    • Failure to respond to first-line therapy 1
    • High local prevalence of CA-MRSA 1

Treatment Duration and Follow-up

  • Complete the full course of prescribed antibiotics even if symptoms improve quickly 1
  • Topical treatment should be used for 5-7 days 6
  • Oral antibiotics should be used for 5-10 days 6
  • Re-evaluate if no improvement after 48-72 hours of therapy 6

Common Pitfalls and Caveats

  • Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 6, 5
  • Oral penicillin V is seldom effective compared to antistaphylococcal penicillins, amoxicillin/clavulanate, cephalosporins, and macrolides 7
  • Topical disinfectants are inferior to antibiotics and should not be used 4, 7
  • Resistance rates are increasing for commonly used antibiotics, particularly erythromycin 5, 4
  • Mupirocin has been shown to be slightly superior to oral erythromycin in multiple studies (risk ratio 1.07) 4

Prevention of Spread

  • Lesions should be kept covered with clean, dry bandages 6
  • Maintain good personal hygiene to prevent spread 6
  • In close-contact settings (schools, military, sports), prompt recognition and treatment are crucial to prevent epidemics 8

References

Guideline

Treatment of Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.